Cargando…
Magnetically Guided Intracartilaginous Delivery of Kartogenin Improves Stem Cell-Targeted Degenerative Arthritis Therapy
BACKGROUND: Degenerative joint disease or osteoarthritis (OA) is a leading cause of disability worldwide. Intra-articular injection is the mainstay nonsurgical treatment for OA. However, dense cartilage and a lack of vasculature often limit the ability of drugs to reach cell or tissue targets at the...
Autores principales: | Jiang, Zengxin, Zhang, Zeng, Li, Shuo, Lin, Sen, Yuan, Hengfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696621/ https://www.ncbi.nlm.nih.gov/pubmed/36438609 http://dx.doi.org/10.2147/IJN.S381815 |
Ejemplares similares
-
Evaluation of Electrospun PCL-PLGA for Sustained Delivery of Kartogenin
por: Elder, Steven, et al.
Publicado: (2022) -
Kartogenin delivery systems for biomedical therapeutics and regenerative medicine
por: Chen, Peixing, et al.
Publicado: (2023) -
Cartilage targeting therapy with reactive oxygen species-responsive nanocarrier for osteoarthritis
por: Jiang, Zengxin, et al.
Publicado: (2022) -
Kartogenin Improves Osteogenesis of Bone Marrow Mesenchymal Stem Cells via Autophagy
por: Yan, Huichun, et al.
Publicado: (2022) -
Creating an Animal Model of Tendinopathy by Inducing Chondrogenic Differentiation with Kartogenin
por: Yuan, Ting, et al.
Publicado: (2016)